Testing the waters — obesity therapeutics

Help bring new energy to the fight against obesity.

Energesis is testing the waters for a potential Regulation Crowdfunding offering on BioTech Funding Portal. Visit our campaign page to watch our video, read about our science, and ask our team questions directly.

 

What you'll find on the campaign page

  • Our science and our lead oral candidate, EGS-2632
  • Our planned use of proceeds
  • Our team, directors and scientific advisors
  • Answers to questions from our founders
 
Visit our campaign on BioTech Funding Portal
Ask Energesis a question
Disclosures

Important information

Testing the waters: No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy securities can be accepted and no part of the purchase price can be received until an offering statement is filed and only through BioTech Funding Portal. Any indication of interest involves no obligation or commitment of any kind.

Preclinical stage: Preclinical results may not translate into human safety or efficacy. Energesis’ product candidates have not been approved by FDA for the treatment of obesity or any other condition.

Risk: Investment offerings are speculative, illiquid, and involve a high degree of risk, including the possible loss of an investor’s entire investment.

About the portal: BioTech Funding Portal LLC, a wholly owned subsidiary of BioTech Social Inc., is a FINRA member funding portal registered with the U.S. Securities and Exchange Commission.

Not advice: This page is not medical, legal, tax, financial, or investment advice. Prospective investors should review any future offering materials carefully and consult their own advisors before making any investment decision.